Helicobacter pylori Infection, Metabolomic Signature and Extra‐gastric Cancer Risk: A Mediation and Mendelian Randomization Analysis
Molecular Carcinogenesis · 2025
DOI: 10.1002/mc.70050 ↗At a glance
Journal article in Molecular Carcinogenesis, 2025. Written by Yan Chen and 15 co-authors. Institution: Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China. Major MEDLINE topics: Helicobacter Infections, Helicobacter pylori, Colorectal Neoplasms, Metabolome. Cited 3 times so far (Crossref); 123 references. Funded by: This study was funded by the National Natural Science Foundation of China (Grants 82125033, 82230110, 82388102) and Major Program of Wuxi Medical Center (WMCM2….
Abstract (original language)
Emerging evidence suggests that Helicobacter pylori ( H. pylori ) infection may contribute to extra‐gastric malignancies, but the mechanisms are unclear. Using untargeted metabolomics data from two prospective Chinese cohorts, we constructed an H. pylori associated metabolomic signature in 1800 baseline participants and evaluated cancer risks using conditional logistic regression in 1:1 matched case‐control studies for lung cancer ( n = 352 pairs), colorectal cancer (CRC; n = 190 pairs), esophageal cancer ( n = 146 pairs), and hepatocellular carcinoma ( n = 163 pairs), with confounder adjustment and sex stratification. Mediation analysis was performed to evaluate the mediating effects of the metabolomic signature and specific plasma metabolites on the observed associations. Mendelian randomization (MR) analysis was conducted to evaluate causal relationships. H. pylori infection was significantly associated with an increased risk of CRC (OR = 1.80, 95% CI: 1.13–2.85), especially driven by males (OR = 3.01, 95% CI: 1.44–6.31), but not with other cancers. Additionally, the H. pylori infection‐related metabolomic signature consisting of 26 metabolites (OR per standard deviation [SD] increment = 1.52, 95% CI: 1.03–2.25) and plasma metabolite methionine sulfone (OR per SD increment = 1.73, 95% CI: 1.16–2.58) were positively associated with CRC risk in males. Mediation analysis indicated partial mediation by the metabolomic signature (12.08%, 95% CI: 0.26–46.88%) and methionine sulfone (16.79%, 95% CI: 0.11–74.76%). MR analysis further supported a potentially causal association between methionine sulfone and CRC (OR = 1.08, 95% CI: 1.02–1.15). Collectively, these results implicate sex‐specific metabolomic alterations, particularly involving methionine sulfone, in mediating the relationship between H. pylori infection and CRC risk in males. These insights advance understanding of CRC pathogenesis and may inform targeted prevention strategies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
- State Key Laboratory Cultivation Base of Biomarkers for Cancer Precision Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, Jiangsu, China.
- Department of Gastroenterology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Wuxi, Jiangsu, China.
- Department of Gastroenterology, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu, China.
ORCID profiles: Dong Hang, Guangfu Jin, Caiwang Yan
Funding
- This study was funded by the National Natural Science Foundation of China (Grants 82125033, 82230110, 82388102) and Major Program of Wuxi Medical Center (WMCM2…
Cite
APA
Chen, Y., Yu, Y., Sun, Q., Zhu, X., Bian, L., Gao, Q., Li, Z., Gao, X., Li, Q., Gu, J., Fang, X., Wang, Y., Zhang, A., Hang, D., Jin, G., & Yan, C. (2025). Helicobacter pylori Infection, Metabolomic Signature and Extra‐gastric Cancer Risk: A Mediation and Mendelian Randomization Analysis. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70050
Vancouver
Chen Y, Yu Y, Sun Q, Zhu X, Bian L, Gao Q, et al. Helicobacter pylori Infection, Metabolomic Signature and Extra‐gastric Cancer Risk: A Mediation and Mendelian Randomization Analysis. Molecular Carcinogenesis. 2025. doi:10.1002/mc.70050
BibTeX
@article{Chen2025,
author = {Chen, Yan and Yu, Yuhui and Sun, Qiufen and Zhu, Xia and Bian, Lijun and Gao, Qian and Li, Zhe and Gao, Xinxiang and Li, Qian and Gu, Jiaying and Fang, Xin and Wang, Yunfei and Zhang, Aiping and Hang, Dong and Jin, Guangfu and Yan, Caiwang},
title = {Helicobacter pylori Infection, Metabolomic Signature and Extra‐gastric Cancer Risk: A Mediation and Mendelian Randomization Analysis},
journal = {Molecular Carcinogenesis},
year = {2025},
doi = {10.1002/mc.70050}
}
EUVIMED